Treatment complexities in psychosis associated with cabergoline treatment in patients having pituitary prolactinomas

Asian J Psychiatr. 2018 Jan:31:129-132. doi: 10.1016/j.ajp.2018.01.011. Epub 2018 Feb 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Cabergoline / adverse effects*
  • Cabergoline / therapeutic use
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use
  • Female
  • GABA Agents / therapeutic use
  • Humans
  • Pituitary Neoplasms / drug therapy*
  • Prolactinoma / drug therapy*
  • Psychoses, Substance-Induced / drug therapy*
  • Psychoses, Substance-Induced / etiology*
  • Valproic Acid / therapeutic use

Substances

  • Dopamine Agonists
  • GABA Agents
  • Valproic Acid
  • Cabergoline